Company Filing History:

8 out of 25

Hvidovre Hospital

patents

3 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

2 out of 19

Kobenhavns Universitet

patents

where one patent can have more than one assignee

Years Active: 2013-2018

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10100346 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2018-10-16),

2. 9683269 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2017-06-20),

3. 8946398 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2015-02-03),

4. 8846891 - Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) (2014-09-30),

5. 8772022 - Hepatitis C virus expressing reporter tagged NS5A protein (2014-07-08),

6. 8569472 - Efficient cell culture system for hepatitis C virus genotype 6A (2013-10-29),

7. 8563706 - Efficient cell culture system for hepatitis C virus genotype 1A and 1B (2013-10-22),

8. 8506969 - Efficient cell culture system for hepatitis C virus genotype 7a (2013-08-13),

Title: Troels Kasper Hoyer Scheel: Shaping the Future of Technology Through Innovation

Introduction:

Troels Kasper Hoyer Scheel is a renowned inventor based in Copenhagen, Denmark, whose dedication to innovation and relentless pursuit of excellence continue to inspire the next generation of inventors worldwide. With a total of 8 patents to his name, Scheel's groundbreaking work in molecular approaches has significantly impacted the field of virology.

Latest Patents:

One of Scheel's latest patents focuses on "Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof." This invention revolves around the production of nucleic acid sequences comprising the genomes of infectious hepatitis C viruses, particularly genotype 3a (strain S52) and genotype 4a (strain ED43). These sequences play a crucial role in the development of vaccines, diagnostic assays for HCV, and screening assays for antiviral agents, highlighting Scheel's innovative contributions to medical research.

Career Highlights:

Throughout his illustrious career, Scheel has made significant strides in the medical and scientific communities. Notable companies he has collaborated with include Hvidovre Hospital and The United States of America, represented by the Department of Health and Human Services. His innovative approach to virology has paved the way for advancements in the treatment and prevention of infectious diseases.

Collaborations:

Scheel's collaborative efforts with esteemed professionals such as Judith Margarete Gottwein and Jens Bukh have further enhanced the impact of his research. Together, they have worked towards developing novel solutions in the field of virology, showcasing Scheel's ability to inspire and collaborate with like-minded individuals to drive innovation forward.

Conclusion:

In conclusion, Troels Kasper Hoyer Scheel's unwavering commitment to innovation and his revolutionary contributions to virology underscore his status as a visionary inventor. His work continues to shape the future of technology, leaving a lasting legacy that will inspire generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.